LAS
VEGAS, June 13, 2024 /PRNewswire/ -- JanOne Inc.
(Nasdaq: JAN), a multidisciplinary organization with a focus on
healthcare and fintech, released today its wholly-owned subsidiary,
ALT5 Sigma, transaction volume for April and May 2024.
According to the Company, ALT5 Sigma transaction
volume reached US$289 million for the
months of April and May 2024
combined, compared to US$151 million
in transaction volume for the months of April and May 2023 combined, representing a year-over-year
increase of 91%.
"Since inception, we have relied
solely on word-of-mouth and
client referrals to grow our business and have
managed a steady growth year-over-year, and now we begin to roll
out our global marketing strategies," said Andre Beauchesne, President of Alt5 Sigma. "The
adoption of cryptocurrencies in many industries is
accelerating and our B2B solutions can be easily integrated into
all business processes from checkout to payouts," further added Mr.
Beauchesne.
About ALT5 Sigma Inc.
Launched in 2018, ALT5 is a fintech
company that provides
next generation blockchain-powered technologies to enable
a migration to a new global financial paradigm. ALT5, through its
subsidiaries, offers two main platforms to its customers: "ALT5
Pay" and "ALT5 Prime". The Company processed over US$1.2 billion in cryptocurrency
transactions in 2023.
ALT5 Pay is a crypto-currency
payment gateway that enables registered and approved global
merchants to accept and make crypto-currency payments
or to integrate the ALT5 Pay payment platform into their
application or operations using the plugin with WooCommerce and or
ALT5 Pay's checkout widgets and APIs. Merchants have the option to
convert to fiat currency (s) automatically or to receive their
payment in digital assets.
ALT5 Prime is an electronic over-the-counter
trading platform that enables registered and approved customers to
buy and sell digital assets. Customers can purchase digital assets
with fiat and, equally, can sell digital assets and receive fiat.
ALT5 Prime is available through a browser-based access mobile phone
application named "ALT5 Pro" that can be downloaded from the Apple
App Store, from Google Play, through ALT5 Prime's FIX API, as well
as through Broadridge Financial Solutions' NYFIX
gateway for approved customers.
About JanOne
JanOne is a unique Nasdaq-listed
multidisciplinary organization with a focus on healthcare and
fintech. JanOne is one of the constituents of the Russell
Microcap Index, starting June 28,
2024. Through its biotech activities, JanOne is
developing innovative, actionable solutions intended to help end
the opioid crisis. JanOne is dedicated to funding resources toward
innovation, technology, and education to find a key resolution to
the national opioid epidemic, which is one of the deadliest and
most widespread in the nation's history. Its drugs in the clinical
trial pipeline have shown promise for their innovative targeting of
the causes of pain as a strategic option for physicians averse to
exposing patients to addictive opioids.
JanOne's ALT5 subsidiary is a global fintech that
provides next generation blockchain powered technologies for the
trading, clearing, settlement, payment, and custodianship of
digital instruments.
Please visit www.janone.com
for additional information.
Forward Looking Statements
This press release contains statements that are
forward-looking statements as defined within the Private Securities
Litigation Reform Act of 1995, including, but not limited to,
statements relating to the statements that JAN 101 will treat PAD,
that JAN 123 will treat CRPS, the timing of the commencement of
clinical trials, that the FDA will permit approval through a
505(b)(2) pathway for JAN 123, that upon approval JAN 101 will
immediately disrupt the PAD market, and other statements, including
words such as "continue", "expect", "intend", "will", "hope"
"should", "would", "may", "potential", and other similar
expressions. This press release also contains statements and links
relating to the profitability and prospective growth of ALT5's
platforms and business, including, but not limited to international
currency risks, third-party or customer credit risks, liability
claims stemming from Alt5's services, and technology challenges for
future growth or expansion. Such statements reflect JanOne's
current view with respect to future events, are subject to risks
and uncertainties, and are necessarily based upon a number of
estimates and assumptions that, while considered reasonable by
JanOne, are inherently subject to significant business, economic,
competitive, political and social uncertainties and
contingencies.
Many factors could cause JanOne's actual results,
performance or achievements to be materially different from any
future results, performance or achievements described in this press
release. Such factors could include, among others, those detailed
in the Company's periodic reports filed with the Securities and
Exchange Commission (the "SEC"). Should one or more of these risks
or uncertainties materialize, or should the assumptions set out in
the section entitled "Risk Factors" in JanOne's filings with
the SEC underlying those forward-looking statements prove
incorrect, actual results may vary materially from those described
herein. These forward-looking statements are made as of the date of
this press release and JanOne does not intend, and does not
assume any obligation, to update these forward-looking statements,
except as required by law. JanOne cannot assure that such
statements will prove to be accurate as actual results and future
events could differ materially from those anticipated in such
statements. Individuals are cautioned that forward-looking
statements are not guarantees of future performance and accordingly
investors are cautioned not to put undue reliance on
forward-looking statements due to the inherent uncertainty
therein.
Media Contact Investor Relations
IR@janone.com
1-800-400-2247
View original content to download
multimedia:https://www.prnewswire.com/news-releases/janones-subsidiary-alt5-reports-91-year-over-year-increase-in-transaction-volume-to-us-289-million-for-april-and-may-2024-302171477.html
SOURCE JanOne Inc.